MDPI and ACS Style
Yamana, Y.; Kanda, T.; Matsumoto, N.; Honda, M.; Kumagawa, M.; Sasaki, R.; Kanezawa, S.; Mizutani, T.; Yamagami, H.; Masuzaki, R.;
et al. Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan. J. Clin. Med. 2021, 10, 5529.
https://doi.org/10.3390/jcm10235529
AMA Style
Yamana Y, Kanda T, Matsumoto N, Honda M, Kumagawa M, Sasaki R, Kanezawa S, Mizutani T, Yamagami H, Masuzaki R,
et al. Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan. Journal of Clinical Medicine. 2021; 10(23):5529.
https://doi.org/10.3390/jcm10235529
Chicago/Turabian Style
Yamana, Yoichiro, Tatsuo Kanda, Naoki Matsumoto, Masayuki Honda, Mariko Kumagawa, Reina Sasaki, Shini Kanezawa, Taku Mizutani, Hiroaki Yamagami, Ryota Masuzaki,
and et al. 2021. "Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan" Journal of Clinical Medicine 10, no. 23: 5529.
https://doi.org/10.3390/jcm10235529